Sangamo’s Research in Alzheimer’s Significantly Reduced Tau Levels in Mice
Acadia Investigates Nuplazid (Pimavanserin) Therapy to Treat Psychosis in Alzheimer’s Patients
June 1, 2017
Seizure-Like Brain Activity May Contribute to Alzheimer’s Development, Study Reports
June 1, 2017
Promising data from Sangamo Therapeutics‘ research programs, including Alzheimer’s disease, were recently announced.
